ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0032099 | An organism of the vegetable kingdom suitable by nature for use as a food, especially by human beings. Not all parts of any given plant are edible but all parts of edible plants have been known to figure as raw or cooked food: leaves, roots, tubers, stems, seeds, buds, fruits, and flowers. The most commonly edible parts of plants are FRUIT, usually sweet, fleshy, and succulent. Most edible plants are commonly cultivated for their nutritional value and are referred to as VEGETABLES. | Plants, Edible|foods plant|Food Plants|Plants, Food|Edible Plant|edible plants|Plant, Edible|Food Plant|Edible Plants|Plant, Food | Plants, Edible |
C0016343 | An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract. | Floxiridina|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|Uridine, 2'-deoxy-5-fluoro-|2'-Deoxy-5-fluorouridine|5FUDR|1-(2-deoxy-beta-D-ribofuranosyl)-5-fluorouracil|5-Fluorouridine Deoxyribose|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|5-FUDR|5-Fluorodeoxyuridine|5-fluoro-2'-deoxy-beta-uridine|5-fluorodeoxyuridine|Product containing floxuridine (medicinal product)|FUDR|Floxuridinum|Floxuridin|beta-5-Fluoro-2'-deoxyuridine|fluorodeoxyuridine|Fluorodeoxyuridine|2'-deoxy-5-fluorouridine|5FDU|5 fluorodeoxyuridine|Floxuridine|FdUrD|5-fluorouridine deoxyribose|5-Fluorouracil Deoxyriboside|floxuridin|Deoxyfluorouridine|FdU|Fluoruridine Deoxyribose|fluorouridine deoxyribose|5-furd|FLOXURIDINE|2-Deoxy-5-fluorouridine|Fluoruridine deoxyribose|FDUR|5-Fluoro-2-desoxyuridine|floxuridine|fluoruridine deoxyribose|5-fluorouracil deoxyriboside|5-FUdR|Fluorouridine Deoxyribose|5-Fluorouracil 2'-deoxyriboside|5 Fluorodeoxyuridine|2-deoxy-5-fluorouridine|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|FUdR|5-Fluorouracil deoxyriboside|fdurd|Floxuridine-containing product|fudr|5-Fluoro-2'-deoxy-beta-uridine|Floxuridine (substance) | floxuridine |
C0009131 | A natural fuel formed by partial decomposition of vegetable matter under certain environmental conditions. | Coal product, NOS|Coal|Coal (substance)|Coal, NOS|Coals|Coal product|coal | Coal |
C0001455 | An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. | Adenosine Cyclic Phosphate|Cyclic adenosine monophosphate|Cyclic Adenosine Monophosphate|3'5'-cyclic ester of AMP|Adenosine Cyclic 3,5 Monophosphate|ADENOSINE CYCLIC PHOSPHATE|Adenosine Cyclic Monophosphate|adenosine 3'5' monophosphate|Cyclic AMP|Adenosine Cyclic 3',5' Monophosphate|cyclic AMP|Adenosine, cyclic 3',5'-(hydrogen phosphate)|cyclic adenosine monophosphate|cyclic amp|Monophosphate, Adenosine Cyclic|cAMP - Cyclic adenosine monophosphate|ADENOSINE CYCLIC 3',5'-PHOSPHATE|Cyclic 3',5'-Monophosphate, Adenosine|AMP, Cyclic|Adenosine Cyclic 3',5'-(Hydrogen Phosphate)|cyclic adenosine monophosphate (cAMP)|cAMP|Cyclic-3',5'-Monophosphate, Adenosine|Adenosine Cyclic 3':5'-Monophosphate|Adenosine Cyclic-3',5'-Monophosphate|Adenosine Cyclic 3',5'-Phosphate|Adenosine Cyclic 3',5'-Monophosphate|3',5'-Monophosphate, Adenosine Cyclic|Cyclic Monophosphate, Adenosine|Cyclic adenosine monophosphate (substance) | cyclic AMP |
C0012054 | A cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed) | N',O'-Dibutyryl-cAMP|BUCLADESINE|Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate|(But)(2) cAMP|Dibutyryl Adenosine 3,5 Monophosphate|Bucladesine|Dibutyryl Adenosine-3',5'-Monophosphate|Adenosine-3',5'-Monophosphate, Dibutyryl|Dibutyryl Cyclic AMP|AMP, Dibutyryl Cyclic|N',O' Dibutyryl cAMP|N(6),0(2')-Dibutyryl Cyclic AMP|Cyclic AMP, Dibutyryl|bucladesine|DBcAMP|Dibutyryl Adenosine 3',5' Monophosphate | Bucladesine |
C0050057 | null | 8-bromo cGMP|8-bromoguanosine 3',5'-cyclic monophosphate|8-bromoguanosine 3',5'-monophosphate|8-Br-cyclic GMP|8-bromocyclic guanosine monophosphate|8-bromoguanosine, cyclic 3',5'-(hydrogen phosphate)|Br CGMP|8-bromo-cGMP|8-bromo-cyclic GMP | 8-bromocyclic GMP |
C0064433 | null | KT5720|KT-5720 | KT 5720 |
C0038833 | A condition that occurs when the obstruction of the thin-walled SUPERIOR VENA CAVA interrupts blood flow from the head, upper extremities, and thorax to the RIGHT ATRIUM. Obstruction can be caused by NEOPLASMS; THROMBOSIS; ANEURYSM; or external compression. The syndrome is characterized by swelling and/or CYANOSIS of the face, neck, and upper arms. | Superior Vena Cava Obstruction|SUPERIOR VENA CAVA OBSTRUCTION|SUPERIOR VENA CAVA SYNDROME|VENA CAVA OBSTRUCTION, SUPERIOR|caval obstruction superior vena|svc syndrome|Superior vena caval syndrome|vena cava superior syndrome|superior vena caval syndrome|Superior Vena Cava Syndrome|superior vena cava obstruction|SVC SYNDROME|superior vena cava syndrome|superior vena caval obstruction|Superior vena cava syndrome|svc obstruction|Cranial vena cava syndrome|cava superior syndromes vena|Superior vena cava syndrome (disorder) | Superior Vena Cava Syndrome |
C0150457 | null | anticoagulant therapy|Anticoagulant therapy (procedure)|Anticoagulant therapy, NOS | Anticoagulant therapy |
C0085278 | The presence of antibodies directed against phospholipids (ANTIBODIES, ANTIPHOSPHOLIPID). The condition is associated with a variety of diseases, notably systemic lupus erythematosus and other connective tissue diseases, thrombopenia, and arterial or venous thromboses. In pregnancy it can cause abortion. Of the phospholipids, the cardiolipins show markedly elevated levels of anticardiolipin antibodies (ANTIBODIES, ANTICARDIOLIPIN). Present also are high levels of lupus anticoagulant (LUPUS COAGULATION INHIBITOR). | APL - Antiphospholipid syndrome|Syndrome, Antiphospholipid|Anti Phospholipid Syndrome|antiphospholipid syndrome|Antibody Syndrome, Antiphospholipid|Antibody Syndrome, Anti-Phospholipid|antiphospholipids syndrome|Anti Phospholipid Antibody Syndrome|Syndrome, Antiphospholipid Antibody|Antiphospholipid syndrome|Antiphospholipid Antibody Syndromes|Syndrome, Anti-Phospholipid Antibody|anti phospholipid syndrome|Antiphospholipid antibody syndrome|antiphospholipid antibody syndrome|APS - Antiphospholipid syndrome|Anticardiolipin syndrome|Antiphospholipid Antibody Syndrome|Syndrome, Anti-Phospholipid|Hughes Syndrome|anticardiolipin syndrome|anti-phospholipid syndrome|Antiphospholipid syndrome (disorder)|Syndrome, Hughes|anti phospholipids syndrome|Anti-Phospholipid Antibody Syndrome|Anti-Phospholipid Syndrome|Antiphospholipid Syndrome | Antiphospholipid Syndrome |
C0085083 | A complication of OVULATION INDUCTION in infertility treatment. It is graded by the severity of symptoms which include OVARY enlargement, multiple OVARIAN FOLLICLES; OVARIAN CYSTS; ASCITES; and generalized EDEMA. The full-blown syndrome may lead to RENAL FAILURE, respiratory distress, and even DEATH. Increased capillary permeability is caused by the vasoactive substances, such as VASCULAR ENDOTHELIAL GROWTH FACTORS, secreted by the overly-stimulated OVARIES. | Ovarian hyperstimulation syndrome (disorder)|OVARIAN HYPERSTIMULATION SYNDROME|Ovarian hyperstimulation syndrome|Ovarian Hyperstimulation Syndrome|Hyperstimulation Syndrome, Ovarian|OHSS|Secondary Meig's syndrome|Hyperstimulation Syndromes, Ovarian|Ovarian Hyperstimulation Syndromes | Ovarian Hyperstimulation Syndrome |
C0559282 | null | Regional osteoporosis (disorder) | Regional osteoporosis |
C0003969 | A condition due to a dietary deficiency of ascorbic acid (vitamin C), characterized by malaise, lethargy, and weakness. As the disease progresses, joints, muscles, and subcutaneous tissues may become the sites of hemorrhage. Ascorbic acid deficiency frequently develops into SCURVY in young children fed unsupplemented cow's milk exclusively during their first year. It develops also commonly in chronic alcoholism. (Cecil Textbook of Medicine, 19th ed, p1177) | deficiency of vitamin c|Deficiencies, Vitamin C|Deficiency, Vitamin C|vitamin C deficiency|Ascorbic Acid Deficiency|Ascorbic acid deficiency disease|Vitamin C Deficiency|vitamin c deficiency|ascorbic acid deficiency|Deficiency of ascorbic acid|of vitamin c deficiency|Ascorbic acid deficiency (disorder)|Vitamin C deficiency disease|Low levels of vitamin C|Ascorbic Acid Deficiencies|Deficiency of vitamin C|Deficiency, Ascorbic Acid|ASCORBIC ACID DEFICIENCY|Ascorbic acid deficiency|Vitamin C Deficiencies|Vitamin C deficiency|Deficiencies, Ascorbic Acid | Ascorbic Acid Deficiency |
C0003872 | A type of inflammatory arthritis associated with PSORIASIS, often involving the axial joints and the peripheral terminal interphalangeal joints. It is characterized by the presence of HLA-B27-associated SPONDYLARTHROPATHY, and the absence of rheumatoid factor. | Psoriatic Arthritis|psoriasis arthropathic|PSORIASIS, ARTHROPATHIC|psoriasis arthropathy|Psoriasis, Arthritic|Arthropathies, Psoriatic|Psoriatic Arthropathies|arthritis psoriatics|PsA (Psoriatic arthritis)|ARTHRITIS, PSORIATIC|PSORIATIC ARTHRITIS|Psoriasis with arthropathy|psoriatic arthropathy|psoriasis arthropathica|Arthropathy, Psoriatic|Psoriatic Arthropathy|Arthritic Psoriasis|arthropathic psoriasis|PA (Psoriatic arthritis)|Psoriatic arthritis|Arthritis Psoriatica|arthritis psoriatic|Psoriatic arthritis (disorder)|psoriatic arthritis|Arthritis, psoriatic|arthritic psoriasis|Psoriasis Arthropathica|Psoriatic arthropathy|Psoriasis with arthropathy (disorder) | Arthritis, Psoriatic |
C0427306 | null | Symmetrical arthritis (disorder)|symmetrical arthritis|Symmetrical joint involvement|arthritis symmetrical | Symmetrical arthritis |
C0008487 | A malignant tumor arising from the embryonic remains of the notochord. It is also called chordocarcinoma, chordoepithelioma, and notochordoma. (Dorland, 27th ed) | Chordomas|notochordoma|CHORDOMA, SUSCEPTIBILITY TO|chordoma|CHDM|Chordoma (disorder)|chordomas|Chordoma (morphologic abnormality)|Chordoma|CHORDOMA, MALIGNANT | Chordoma |
C0860843 | null | scintigraphy thyroid | thyroid scintigraphy |
C1518345 | A lesion characterized by the presence of one or more nodules. | Nodular lesion|Nodular Lesion | Nodular lesions |
C0198373 | null | Thoracoscopy and biopsy|thoracoscopic biopsy|Thoracoscopy and biopsy of intrathoracic organ (procedure)|Thoracoscopy with biopsy|Thoracoscopic biopsy|Thoracoscopy with biopsy (procedure)|biopsies thoracoscopic | Thoracoscopy and biopsy of intrathoracic organ |
C0040132 | A highly vascularized endocrine gland consisting of two lobes joined by a thin band of tissue with one lobe on each side of the TRACHEA. It secretes THYROID HORMONES from the follicular cells and CALCITONIN from the parafollicular cells thereby regulating METABOLISM and CALCIUM level in blood, respectively. | Thyroid gland|Thyroid structure|thyroid|thyroids|GLAND, THYROID|THYROID GLAND|Thyroid Glands|Thyroid gland, NOS|Thyroid structure (body structure)|thyroid glands|Glandula thyroidea|Thyroid Gland|thyroid gland|Glands, Thyroid|Thyroids|Head and Neck, Thyroid|Thyroid|Thyroid, NOS|Gland, Thyroid | Thyroid Gland |
C0579085 | null | Back problem (finding)|back problems|Back problem|back problem | Back problem |
C0016223 | protein containing a flavin ribonucleotide as a prosthetic group; most are enzymes; many are found in complexes containing metal ions and an iron-sulfur complex or a heme; they catalyze a wide variety of oxidation-reduction reactions. | Flavoprotein|Flavoprotein, NOS|Flavoproteins|flavoprotein|Flavoprotein (substance) | Flavoproteins |
C0016223 | protein containing a flavin ribonucleotide as a prosthetic group; most are enzymes; many are found in complexes containing metal ions and an iron-sulfur complex or a heme; they catalyze a wide variety of oxidation-reduction reactions. | Flavoprotein|Flavoprotein, NOS|Flavoproteins|flavoprotein|Flavoprotein (substance) | Flavoproteins |
C0073910 | null | tetradecanoyl-CoA|myristoyl-CoA|coenzyme A, tetradecanoyl-|myristoyl-coenzyme A | S-tetradecanoyl-coenzyme A |
C0004836 | A steam bath in a small wooden room where water is thrown on a stove or rocks to create the steam. A cool bath or shower completes the treatment. | sauna|Finnish Bath|Bath, Finnish|saunas|Finnish baths|Finnish Sauna|Sauna | Baths, Finnish |
C0003625 | A plant genus in the family ROSACEAE, order Rosales, subclass Rosidae. It is best known as a source of the edible fruit (apple) and is cultivated in temperate climates worldwide. | Malus, NOS|Malus (organism)|Apple|Malus | Genus Malus |
C0814999 | HEMATOPOIETIC PROGENITOR CELLS that have migrated to the THYMUS where they differentiate into T-LYMPHOCYTES. Thymocytes are classified into maturational stages based on the expression of CELL SURFACE ANTIGENS. | Thymic lymphocyte|Thymic lymphocyte (cell)|thymocytes|Thymocyte|thymocyte|Thymocytes | thymocyte |
C0301161 | null | Dyes, Azo|Azo dye (substance)|Azo dye|azo-dye|azo dyes|azo dye|Azo-dye | Azo Dyes |
C0920324 | null | Remedies, Homeopathic|homeopathic remedy|homoeopathic medicine|drugs homeopathic|homeopathic medicine|Homeopathic Remedies|homeopathic medicines|homeopathic drugs|homoeopathic medicines|Homeopathic medicine (product)|Homoeopathic medicine|homeopathic drug|Homeopathic medicine|homeopathic remedies|homeopathic products | Homeopathic Remedies |
C0043367 | An aromatic hydrocarbon composed of a benzene ring linked to two methyl groups and that exists in three isoforms depending on the sites where the methyl groups are attached. Xylene is used for various industrial applications. | Dimethyl benzene|xylene|Dimethylbenzene|Xylol|Dimethylbenzene (substance)|Xylene|XYLENE (MIXED ISOMERS)|XYLENE|dimethylbenzene | xylene |
C0030788 | Removal of all of the organs and adjacent structures of the pelvis. It is usually performed to surgically remove cancer involving the bladder, uterine cervix, or rectum. (Stedman, 25th ed) | Pelvic exenteration (procedure)|Removal of ovaries, tubes, uterus, vagina, bladder, and urethra|Exenterations, Pelvic|pelvic evisceration|Pelvic exenteration, NOS|Pelvic Exenterations|Pelvic Exenteration|pelvic exenterations|Pelvic evisceration|Removal of ovaries, tubes, uterus, vagina, bladder, and urethra with removal of sigmoid colon and rectum|Pelvic exenteration|pelvic exenteration|Exenteration of pelvis|Exenteration, Pelvic | Pelvic Exenteration |
C0341662 | null | mixer|Mixer|Mixer (occupation) | Mixer (occupation) |
C0376453 | A family of RNA plant viruses with flexuous, filamentous particles and consisting of six genera: POTYVIRUS; Ipomovirus; Macluravirus; Rymovirus; Tritimovirus; and Bymovirus. All members of the family form cytoplasmic cylindrical inclusion bodies during infection. | Potyviridae | Potyviridae |
C0032583 | Proteins which are synthesized as a single polymer and then cleaved into several distinct proteins. | null | Polyproteins |
C0032583 | Proteins which are synthesized as a single polymer and then cleaved into several distinct proteins. | null | Polyproteins |
C0206273 | A large genus of plant viruses of the family POTYVIRIDAE which infect mainly plants of the Solanaceae. Transmission is primarily by aphids in a non-persistent manner. The type species is potato virus Y. | Potyvirus|Potyviruses | Potyvirus |
C1212918 | null | Zantedeschia mosaic potyvirus | Zantedeschia mosaic virus |
C0563527 | null | Colposuspension (procedure)|Suspension of vagina|Colposuspension|colposuspension | Colposuspension (procedure) |
C0032787 | Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. | complications post op|postoperative complications|Postoperative complication (disorder)|Complication, Postoperative|Postoperative Complication|Postoperative complication, NOS|Postoperative problem|Postoperative complication NOS|complications postoperative|Complications, Postoperative|Postoperative complication|complication postoperative|postoperative complication | Postoperative Complications |
C0231528 | Painful sensation in the muscles. | muscle pains|Myosalgia|Pain, Muscle|Muscle Sorenesses|pains muscle|muscular pains|Myalgias|MUSCLE DISCOMFORT|muscle aches|GENERALIZED MYALGIA|Muscle pain|Muscle Soreness|MYALGIAS|Myodynia|myalgic|aches muscles|Aching muscles|Myalgia|myalgia|myalgias|ache muscle|muscles pains|MUSCLE ACHE|pain muscular|Muscle soreness|Muscle pain (finding)|pain muscles|Soreness, Muscle|MUSCULAR PAIN|Myoneuralgia|Myalgic|MYALGIA|muscles pain|PAIN MUSCLE|Muscle ache|muscle discomfort|muscle pain|muscular pain|aches muscle|pain muscle|MUSCLE PAIN|ache muscles|muscle soreness|MUSCLE SORENESS|Muscle aches|myodynia|Muscle Pain|Pains, Muscle|muscle ache | Myalgia |
C0042815 | A pain scale marked off like a ruler from 0 to 10 on which the patient marks the current level of pain experienced. | Visual Analogue Pain Scale|visual analog scales|Visual analog pain scale|VAPS - Visual analog pain scale|Pain VAS|Visual analog pain scale (assessment scale)|visual analog pain scale|visual analogue scales|pain visual analogue scale|Visual Analog Pain Scale|Visual analogue pain scale|VAS|VAPS - Visual analogue pain scale|visual analog scale|analog pain scales visual|visual analogue scale | Visual Analog Pain Scale |
C0344452 | A pituitary prolactin cell adenoma of less than 10 mm diameter. [HPO:probinson] | Microprolactinomas|Microprolactinoma|Microprolactinoma (disorder) | Microprolactinoma |
C0033893 | A headache associated with muscle tightness which may radiate to other parts of the body. | Tension-type headache|Headache, Tension|stress headaches|Tension Headache|headache tension|Tension headache|headaches tensions|headaches muscle tension|Stress Headache|Tension-type headache (disorder)|Muscle contraction headache syndrome|Tension-Type Headaches|Headaches, Tension-Type|muscle tension headache|tension-type headache|Tension type headache|headaches stress|Psychogenic Headaches|Psychogenic Headache|Headache, Idiopathic|tension-type headaches|Tension-type Headache|Stress headache|Headaches, Idiopathic|Tension Type Headache|TENSION HEADACHE|Headache, Psychogenic|Stress Headaches|Headaches, Stress|Tension-Type Headache|stress headache|Tension type headache, unspecified|headaches tension-type|headache stress|headaches tension|HEADACHE, TENSION|Psychogenic headache (finding)|tension headaches|Idiopathic Headaches|Headaches, Psychogenic|tension headache|Headache, Tension-Type|Headaches, Tension|headaches tension type|HEADACHE, PSYCHOGENIC|Tension Headaches|Psychogenic headache|Headache, Stress|tension type headache|PSYCHOGENIC CEPHALALGIA|Idiopathic Headache|MUSCLE TENSION HEADACHE | Tension Headache |
C0236018 | null | Aura (finding)|Aura, NOS|Observation of aura|aura|Auras|AURA|auras|Aura | Aura |
C0002453 | Absence of menstruation. | Amenorrhea|absence of menstruation|MENSES LACK OF|amenia|Absence of menstruation, NOS|Amenorrhoea|CESSATION OF MENSES|AMENORRHEA|Amenorrhea, NOS|amenorrhea|Amenorrhoea, NOS|lack of menses|Abnormal absence of menstruation|menstruation absence|Amenorrhea (finding)|AMENORRHOEA|Absence of menstruation|cessation of menses|amenorrhoea | Amenorrhea |
C0156404 | Deviations from the normal process; e.g. delayed, difficult, profuse, scanty, unusual bleeding, etc. | Irregular Menses|irregular uterine bleeding|Menstrual irregularities|irregular menstruations|MENSES IRREGULAR|Irregular uterine bleeding|irregular periods|irregular menstruation|Irregular periods|irregular menstrual period|Irregular menstrual cycle|MENSTRUAL IRREGULARITY|irregular menses|irregular period|Irregular menstrual bleeding|Irregular Menstruation|Variable menstrual cycle|Menstruation, Irregular|irregular menstrual periods|Menstrual periods irregular|Irregularity, Menstrual|Irregularities, Menstrual|Irregular menses|Menstrual Irregularity|irregular menstrual bleeding|Irregular menstruation|IRREGULAR UTERINE BLEEDING|menstrual irregularity|Menses, Irregular|Irregular periods (finding)|Irregular menstrual cycles|irregular menstrual cycle|Menstrual Irregularities|Menstrual irregularity | Irregular Menstruation |
C0107994 | A synthetic ergoline derivative and a long-acting dopamine receptor agonist with high affinity for the dopamine D2 receptor. Cabergoline exerts an inhibitory effect on prolactin secretion by acting on dopamine receptors present in pituitary lactotrophs. This drug also binds to dopamine D2 receptors in the corpus striatum, thereby mimicking the actions of dopamine on motor control. Cabergoline also possesses antioxidant and neuroprotective properties due to its free radical scavenging activity. Cabergoline is used in the treatment of Parkinson's disease and in the treatment of hyperprolactinemia. | (8R)-6-allyl-N-[3-(dimethylamino)propyl]-N-(ethylcarbamoyl)ergoline-8-carboxamide|Cabergoline|1-((6-allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergolina|1-[(6-allylergoline-8β-yl)carbonyl]-1-[3-(dimethylamino)propyl]-3-ethylurea|1-((6-allylergolin-8β-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|Cabergoline-containing product|cabergoline|Product containing cabergoline (medicinal product)|(8β)-N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-ergoline-8-carboxamide|Cabergoline (substance)|1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea|1-ethyl-3-(3'-dimethylamionpropyl)-2-(6'-allylergoline-8'β-carbonyl)urea|Cabergolinum|Ergoline-8-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propen-1-yl)-, (8beta)-|CABERGOLINE|cabergoline parkinsons | cabergoline |
C1142375 | null | Magnetic resonance imaging of whole body|Magnetic resonance imaging of whole body (procedure)|MRI of whole body | Nuclear magnetic resonance imaging whole body |
C0005898 | Anatomical areas of the body. | Region, Body|body region|body regions|Body region, NOS|Regions, Body|Anatomic Region|Body Regions|anatomic region|Body region|ANTREG|Body region structure|anatomical site|TOPOGRAPHIC REGIONS: GENERAL TERMS|anatomical sites|Topographic region|Body Region|TOPOGRAPHIC REGIONS|Anatomic region, NOS|Anatomic region|Topographic region, NOS|Body region structure (body structure) | Body Regions |
C0179412 | Implants used to reconstruct and/or cosmetically enhance the female breast. They have an outer shell or envelope of silicone elastomer and are filled with either saline or silicone gel. The outer shell may be either smooth or textured. | breast implant|Implants, Breast|Mammary prosthesis|Breast Implants|Breast Implant|Implant, Breast|Breast prosthesis|Breast prosthesis, device (physical object)|Internal Breast Prosthesis|Breast Prostheses, Internal|Breast implant|Breast prosthesis, device|Breast Prosthesis, Internal|Breast implants|Internal Breast Prostheses|Prostheses, Internal Breast|Prosthesis, Internal Breast | Breast Prosthesis, Internal |
C0003506 | Surgery performed with the purpose of replacing a degenerated, calcified, malformed, dysfunctional, etc. aortic valve with a bioprosthetic, homograft, or autograft valve. | Excision and replacement of aortic valve, NOS|aortic valve replacement|AVR - Aortic valve replacement|replacement aortic valve|of aortic valve replacement|aortic replacement valve|Replacement of aortic valve (procedure)|AORTIC VALVE REPLACEMENT|aortic replacements valve|Replacement of aortic valve|Replacement of aortic valve, NOS|Excision and replacement of aortic valve|Aortic Valve Replacement | Replacement of aortic valve (procedure) |
C0018944 | A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue. | Haematoma|haematomas|hematomas|haematoma|Hematoma (morphologic abnormality)|hematoma|HEMATOMA|Hematomas|Haematoma, NOS|Hematoma (disorder)|Hematoma|Hematoma, NOS|HAEMATOMA | Hematoma |
C0752118 | A heterogenous group of transient or low voltage activated type CALCIUM CHANNELS. They are found in cardiac myocyte membranes, the sinoatrial node, Purkinje cells of the heart and the central nervous system. | Calcium Channels, T-Type|Transient Type Calcium Channels|Transient-Type Calcium Channels|Calcium Channel (T-Type)|Channel, T-Type Calcium|T Type Voltage Dependent Calcium Channels|Channels, T-Type Calcium|Calcium Channels, Transient-Type|Calcium Channel, T-Type|T Type Calcium Channel|Channels, Transient-Type Calcium|T Type Calcium Channels|T-Type Calcium Channels|T-Type Calcium Channel|Calcium Channels, T Type|T Type VDCC|T-Type Voltage-Dependent Calcium Channels|T-Type VDCC|VDCC, T-Type | T-Type Calcium Channels |
C0006685 | Voltage-dependent cell membrane glycoproteins selectively permeable to calcium ions. They are categorized as L-, T-, N-, P-, Q-, and R-types based on the activation and inactivation kinetics, ion specificity, and sensitivity to drugs and toxins. The L- and T-types are present throughout the cardiovascular and central nervous systems and the N-, P-, Q-, & R-types are located in neuronal tissue. | Ion Channel, Calcium|VDCC|calcium channel|Receptors, Calcium Channel Blocker|Calcium channels|Calcium Channel|Calcium Ion Channels|Calcium Channel Blocker Receptors|Channels, Voltage-Dependent Calcium|calcium ion channel|calcium channels|Calcium Channels|Calcium Ion Channel|Receptors, Calcium Channel Antagonist|Voltage Dependent Calcium Channels|Calcium Channels, Voltage-Dependent|Calcium Channel Antagonist Receptors|Voltage-Dependent Calcium Channels|Calcium Channel Blocker Receptor|Ion Channels, Calcium|Calcium Channel Antagonist Receptor | Calcium Channel |
C0442965 | null | cosmetic procedure|Cosmetic procedure|cosmetic procedures|Cosmetic|Cosmetic procedure (qualifier value) | Cosmetic procedure |
C0949546 | null | Myosin Regulatory Light Chains | Myosin Regulatory Light Chain |
C0161922 | null | Repair of urethra|Urethroplasty|urethral repair|repair urethral|urethra repair|Repair of urethra, NOS|Urethroplasty, NOS|Repair of urethra (procedure)|urethroplasty | Repair of urethra |
C0334121 | A multinodular intermediate fibroblastic neoplasm that arises from soft tissue or viscera, in children and young adults. It is characterized by the presence of spindle-shaped fibroblasts and myofibroblasts, and a chronic inflammatory infiltrate composed of eosinophils, lymphocytes, and plasma cells. | Inflammatory pseudotumor|Pseudotumors, Inflammatory|Pseudotumor, inflammatory|Inflammatory Pseudotumor|Inflammatory Myofibroblastic Neoplasm|inflammatory pseudotumors|myofibroblastic tumors|inflammatory pseudotumor|Inflammatory pseudotumor (morphologic abnormality)|Inflammatory myofibroblastic tumour|myofibroblastic tumor|Inflammatory myofibroblastic tumor|IMT|myofibroblastic tumour|Inflammatory Fibrosarcoma|Inflammatory myofibroblastic tumor (disorder)|pseudotumor inflammatory|Inflammatory Pseudotumors|Myofibroblastic tumor (morphologic abnormality)|Myofibroblastic tumour|Pseudotumor, Inflammatory|Myofibroblastic tumor|Inflammatory pseudotumour|Inflammatory Myofibroblastic Tumor|inflammatory pseudotumour | Inflammatory Myofibroblastic Tumor |
C0334463 | A soft tissue sarcoma that usually occurs in the limbs, most commonly the legs, and may also occur in the abdomen. | Malignant Fibroxanthoma|Malignant Fibrous Histiocytoma of the Soft Tissue and Bone|Fibroxanthoma, malignant|Malignant Fibrous Histiocytomas|Malignant Fibrohistiocytic Tumor|Unclassified Pleomorphic Sarcoma (Formerly "MFH")|Malignant fibroxanthoma|Malignant Fibrous Histiocytoma|Tumors, Malignant Fibrohistiocytic|Storiform-Pleomorphic Malignant Fibrous Histiocytoma|Unclassified Pleomorphic Sarcoma (Formerly "Malignant Fibrous Histiocytoma")|UPS|Fibrous histiocytoma, malignant|Malignant fibrous histiocytoma|Malignant fibrous histiocytoma (disorder)|Histiocytomas, Malignant Fibrous|Fibrous histiocytoma, malignant (morphologic abnormality)|Undifferentiated Pleomorphic Sarcoma|fibrous histiocytoma malignant|Histiocytoma, Malignant Fibrous|Fibrohistiocytic Tumors, Malignant|Fibrous Histiocytoma, Malignant|Malignant Fibrous Histiocytoma of Soft Tissue and Bone|Malignant Fibrohistiocytic Tumors|FIBROSARCOMA, PLEOMORPHIC, MALIGNANT|Fibrohistiocytic Tumor, Malignant|MFH|Undifferentiated high grade pleomorphic sarcoma|Fibroxanthosarcoma|Fibrous Histiocytomas, Malignant|Histiocytoma, Fibrous, Malignant|malignant fibrous histiocytoma|Unclassified Pleomorphic Sarcoma|malignant fibrous cytoma|Tumor, Malignant Fibrohistiocytic|Undifferentiated Pleomorphic Soft Tissue Sarcoma | Malignant Fibrous Histiocytoma |
C1336052 | A benign or malignant neoplasm characterized by the presence of neoplastic spindle cells. | Spindle Cell Tumor|Spindle Cell Neoplasm | Spindle Cell Neoplasm |
C0033844 | null | Pseudotumour|Pseudotumor|Pseudotumor, NOS|pseudotumor|Pseudotumor (morphologic abnormality)|Pseudotumors|pseudotumors|pseudotumour | Pseudotumor |
C0038461 | A genus of parasitic nematodes widely distributed as intestinal parasites of mammals. | Strongyloides species|Strongyloides|Strongyloides (organism)|Strongyloides, NOS|strongyloides|Strongyloide|Genus: Strongyloides | Strongyloides |
C0108280 | A catenin that binds F-ACTIN and links the CYTOSKELETON with BETA CATENIN and GAMMA CATENIN. | Catenin, alpha|alpha Catenin|Cadherin Associated Protein 102 kDa|Cadherin-Associated Protein 102 kDa|alphaE Catenin|Catenin, alpha-1|alpha-Catenin|alpha E-Catenin|Catenin, alphaE|E-Catenin, alpha|alpha-1 Catenin|alpha E Catenin|alpha catenin|alpha 1 Catenin|CAP102 Protein | alpha Catenin |
C1156245 | null | Growth pattern (observable entity)|growth pattern|Growth pattern|growth patterns | Growth pattern |
C0872382 | null | glucose sensor|GLUCOSE SENSOR|glucose sensors | glucose sensor device |
C0150544 | Actions performed to control diabetic conditions | Diabetic Care|Diabetic care (regime/therapy)|Diabetic care|care diabetic|caring diabetic|care diabetics|diabetic care | Diabetic care |
C0027361 | Persons as individuals (e.g., ABORTION APPLICANTS) or as members of a group (e.g., HISPANIC AMERICANS). It is not used for members of the various professions (e.g., PHYSICIANS) or occupations (e.g., LIBRARIANS) for which OCCUPATIONAL GROUPS is available. | person|People|Person (person)|persons|Person|Individual|Persons|peoples|people | Persons |
C0006631 | Calcium-dependent cell adhesion proteins. They are important in the formation of ADHERENS JUNCTIONS between cells. Cadherins are classified by their distinct immunological and tissue specificities, either by letters (E- for epithelial, N- for neural, and P- for placental cadherins) or by numbers (cadherin-12 or N-cadherin 2 for brain-cadherin). Cadherins promote cell adhesion via a homophilic mechanism as in the construction of tissues and of the whole animal body. | Cadherins|cadherin|Cadherin|LCAM (liver cell adhesion molecule) | Cadherins |
C0006631 | Calcium-dependent cell adhesion proteins. They are important in the formation of ADHERENS JUNCTIONS between cells. Cadherins are classified by their distinct immunological and tissue specificities, either by letters (E- for epithelial, N- for neural, and P- for placental cadherins) or by numbers (cadherin-12 or N-cadherin 2 for brain-cadherin). Cadherins promote cell adhesion via a homophilic mechanism as in the construction of tissues and of the whole animal body. | Cadherins|cadherin|Cadherin|LCAM (liver cell adhesion molecule) | Cadherins |
C0300423 | Cadherin-5 (784 aa, ~88 kDa) is encoded by the human CDH5 gene. This protein is involved in endothelial cell polarity and cell-cell adhesion. | cadherin 5|CDH5|vascular endothelial cadherin|Cadherin 5|Cadherin-5|Vascular Endothelial Cadherin 1|cadherin-5|CD144 Antigen|Vascular Endothelial Cadherin|VE-cadherin|VE-Cadherin|CD144 antigen|7B4 Antigen|Endothelial-Specific Cadherin|7B4 antigen | cadherin 5 |
C0024221 | A benign tumor resulting from a congenital malformation of the lymphatic system. Lymphangioendothelioma is a type of lymphangioma in which endothelial cells are the dominant component. | Benign lymphangioma|Lymphangioma|Lymphangioma, any site|Benign lymphangioma (morphologic abnormality)|lymphangioma|Lymphangioma, no ICD-O subtype|Lymphangioma, no International Classification of Diseases for Oncology subtype|Lymphangioma, NOS|Lymphangioma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)|LYMPHANGIOMA, BENIGN|congenital lymphangioma|Lymphangiomas|Lymphangioma of unspecified site|Congenital lymphangioma|Lymphangioma morphology|Lymphangioma, site unspecified|lymphangiomas|Congenital lymphangioma (disorder)|Lymphangioma (disorder) | Lymphangioma |
C0123091 | A dibenzothiazepine derivative with antipsychotic property. Quetiapine fumarate antagonizes serotonin activity mediated by 5-HT 1A and 5-HT2 receptors. With a lower affinity, this agent also reversibly binds to dopamine D1 and D2 receptors in the mesolimbic and mesocortical areas of the brain leading to decreased psychotic effects, such as hallucinations and delusions. In addition, quetiapine also binds to other alpha-1, alpha-2 adrenergic and histamine H1 receptors. | quetiapine|QUEtiapine|Product containing quetiapine (medicinal product)|Quetiapinum|2-(2-(4-dibenzo(b,f)(1,4)thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol|Quetiapine-containing product|2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|Quetiapine|Quetiapina|Quetiapine (substance)|QUETIAPINE|Quétiapine | quetiapine |
C1335788 | null | Ringed Sideroblasts 15% or More of Erythroid Precursors|Ringed Sideroblasts 15 Percent or More of Erythroid Precursors | Ring Sideroblasts 15 Percent or More of Erythroid Precursors |
C1335788 | null | Ringed Sideroblasts 15% or More of Erythroid Precursors|Ringed Sideroblasts 15 Percent or More of Erythroid Precursors | Ring Sideroblasts 15 Percent or More of Erythroid Precursors |
C0949632 | An electrophoretic technique for assaying the binding of one compound to another. Typically one compound is labeled to follow its mobility during electrophoresis. If the labeled compound is bound by the other compound, then the mobility of the labeled compound through the electrophoretic medium will be retarded. | Assays, Bandshift Mobility|EMSA Electrophoretic Techniques|Assay, Bandshift Mobility|gel shift assay|Mobility Shift Assay|Bandshift Mobility Assay|Techniques, EMSA Electrophoretic|Band Shift Mobility Assay|EMSA Electrophoretic Technique|Electrophoretic Techniques, EMSA|Mobility Assays, Bandshift|Assays, Mobility Shift|Electrophoretic Mobility Shift Assay|Electrophoretic Technique, EMSA|Mobility Assay, Bandshift|Technique, EMSA Electrophoretic|Bandshift Mobility Assays|electrophoretic mobility shift assay|mobility shift assay|EMSA|Assay, Mobility Shift|Gel Shift Assay|Mobility Shift Assays | Electrophoretic Mobility Shift Assay |
C0079595 | A method of producing pictures of areas inside the body. | diagnostic imaging technique|Imaging|imaging|Imaging technique|Imaging technique (qualifier value)|Medical Imaging|imaging procedure|imaging technique|Imaging (Procedure)|imaging techniques|imaging technic|medical imaging|Diagnostic Imaging Technique|imaging procedures|Imaging Technique|Imaging Procedures | Imaging Techniques |
C0040551 | A species of parasitic nematode found in the intestine of dogs. Lesions in the brain, liver, eye, kidney, and lung are caused by migrating larvae. In humans, these larvae do not follow normal patterns and may produce visceral larva migrans (LARVA MIGRANS, VISCERAL). | Toxocara canis|canis, Toxocara|Toxocara cani|Toxocara canis (organism)|Dog Roundworm|TOXOCARA CANIS|toxocara canis|Dog ascarid|Ascaris canis | Toxocara canis |
C0038002 | Enlargement of the spleen. | SPLEEN ENLARGED|Enlargement of spleen, NOS|SPLEEN ENLARGEMENT|Splenomegaly|enlarg spleen|Enlargement of spleen|spleen large|enlargement spleen|SPLENOMEGALY|large spleen|splenomegaly|Large spleen|Splenomegaly, NOS|Spleen enlarged|Enlarged Spleen|spleen enlargement|enlarged spleen|spleen enlarged|Splenomegaly (disorder)|enlargement of spleen|Increased spleen size|Spleen, Enlarged | Splenomegaly |
C0004810 | A phylum of fungi that produce their sexual spores (basidiospores) on the outside of the basidium. It includes forms commonly known as mushrooms, boletes, puffballs, earthstars, stinkhorns, bird's-nest fungi, jelly fungi, bracket or shelf fungi, and rust and smut fungi. | Basidiomycota|PHYLUM DIKARYOMYCOTA|basidiomycete|Phylum Basidiomycota (organism)|basidiomycetes|Basidiomycete|Basidiomycotas|Phylum Basidiomycota|Dikaryomycota|basidiomycota|Basidiomycetes | Basidiomycota |
C0036450 | Venoms from animals of the order Scorpionida of the class Arachnida. They contain neuro- and hemotoxins, enzymes, and various other factors that may release acetylcholine and catecholamines from nerve endings. Of the several protein toxins that have been characterized, most are immunogenic. | Scorpion Venoms|Scorpion venom (substance)|Scorpion Venom|Scorpion venom|Venom, Scorpion|Venoms, Scorpion|Scorpions--Venom|scorpion venom | Scorpion Venoms |
C1518101 | In MALDI-TOF, a laser pulse is fired into a protein or peptide sample contained in a light-absorbing matrix. A small explosion vaporizes and ionizes the sample. In the presence of a high electric field, peptide ions are accelerated down an evacuated flight tube. Because large particles travel more slowly than small ones, the masses of the ionized particles are determined by measuring their arrival time at the end of the tube | matrix-assisted laser desorption/ionization time of flight mass spectrometry|Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry|Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry|Matrix-Assisted Laser Desorption Ionization Time-of-Flight MS|MALDI-TOF Mass Spectrometry|MALDI-TOF | Matrix-Assisted Laser Desorption/Ionization-Time of Flight Mass Spectrometry |
C0030966 | Derived proteins or mixtures of cleavage products produced by the partial hydrolysis of a native protein either by an acid or by an enzyme. Peptones are readily soluble in water, and are not precipitable by heat, by alkalis, or by saturation with ammonium sulfate. (Dorland, 28th ed) | Peptones|peptone|peptones|Peptone | peptones |
C0006717 | null | calcium pyrophosphate dihydrate|Pyrophosphate Dihydrate, Calcium | Calcium Pyrophosphate Dihydrate |
C1306065 | null | DEVELOPMENTAL DYSPLASIA OF THE HIP 1|DDH1 | DEVELOPMENTAL DYSPLASIA OF THE HIP 1 |
C1533699 | A monoclonal antibody combined with a toxic substance that is used to treat certain types of acute myeloid leukemia in older patients and is being studied in the treatment of other types of cancer. Monoclonal antibodies are made in the laboratory and can locate and bind to substances in the body, including cancer cells. Mylotarg is a type of antibody-drug conjugate. | Gemtuzumab ozogamicin (substance)|Gemtuzumab ozogamicin-containing product|GEMTUZUMAB OZOGAMICIN|Gemtuzumab-Ozogamicin|gemtuzumab ozogamicin|hP67.6-Calicheamicin|Gemtuzumab Ozogamicin|Gemtuzumab ozogamicin|Calicheamicin-Conjugated Humanized Anti-CD33 Monoclonal Antibody|Product containing gemtuzumab ozogamicin (medicinal product) | gemtuzumab ozogamicin |
C0027947 | A decrease in the number of NEUTROPHILS found in the blood. | Neutropenic disorder (disorder)|Neutropenic disorder|Disorder characterized by neutropenia|Neutropenia, NOS|Neutropenias|NEUTROPHILS DECREASED|Neutropenia|NEUTROPENIA|Neutropenia, unspecified|neutropenia | Neutropenia |
C0020580 | Absent or reduced sensitivity to cutaneous stimulation. | Impaired sensation|Tactile hypesthesia|Hypoaesthesia (reduced sensation)|HYPOESTHESIA|Hypesthesias, Tactile|Sensations, Reduced|Numbness|Hypoesthesia|Sensation, Impaired|decreased sensation|Impaired Sensations|Sensory impairment|impaired sensation|hypesthesias|Tactile hypesthesia (finding)|Hypesthesia|Tactile Hypesthesias|Hypesthesia (finding)|Tactile Hypesthesia|Sensations, Impaired|Reduced sensation of skin|Reduced sensation|Sensation, Reduced|sensation impaired|HYPOAESTHESIA|DECREASED SENSATION|Hypesthesias|Hypoaesthesia|Hypoesthesia (reduced sensation)|Hypoesthesias|Reduced Sensations|HYPESTHESIA|Hypesthesia, Tactile|Reduced sensation of skin (finding)|Decreased Sensitivity|hypesthesia|hypoaesthesia|numbness|Reduced Sensation|Impaired Sensation|hypoesthesia|Limited sensation|Tactile hypaesthesia|Cutaneous hypoesthesia | Hypesthesia |
C0032290 | A type of lung inflammation resulting from the aspiration of food, liquid, or gastric contents into the upper RESPIRATORY TRACT. | Aspiration pneumonia, NOS|Pneumonias, Aspiration|Aspiration Pneumonias|Pneumonia, Aspiration|ASPIRATION PNEUMONIA|Aspiration pneumonia NOS|Aspiration pneumonia (disorder)|pneumonia, inhalation|aspiration pneumonitis|Aspiration pneumonitis, NOS|Pneumonia, inhalation|pneumonia aspiration|ASPIRATION PNEUMONIAS|PNEUMONIA, ASPIRATION|Aspiration Pneumonia|Pneumonia, aspiration|inhalation pneumonia|aspiration pneumonia|Aspiration pneumonia|Inhalation pneumonia | Aspiration Pneumonia |
C0442192 | null | supraglottic|Supraglottic|Supraglottic (qualifier value) | Supraglottic |
C0008373 | A non-neoplastic mass of keratin-producing squamous EPITHELIUM, frequently occurring in the MENINGES; bones of the skull, and most commonly in the MIDDLE EAR and MASTOID region. Cholesteatoma can be congenital or acquired. Cholesteatoma is not a tumor nor is it associated with high CHOLESTEROL. | CHOLESTEATOMA|Cholesteatoma, NOS|Cholesteatoma, unspecified|Cholesteatomas|Epidermoid cholesteatoma|cholesteatoma|Cholesteatoma (morphologic abnormality)|Cholesteatoma (disorder)|Cholesteatoma|cholesteatomas | Cholesteatoma |
C0034535 | null | Radiation Syndrome|radiation syndromes|Radiation Syndromes|Syndrome, Radiation|radiation sickness|sickness radiation|diseases radiation|radiation disease|radiation syndrome|Syndromes, Radiation|disease radiation | Radiation Syndrome |
C0029445 | Death of a bone or part of a bone, either atraumatic or posttraumatic. | bone necrosis|NECROSIS BONE|BONE NECROSIS|Necrosis, Bone|Bone Necrosis|Necroses, Bone|Osteochondronecrosis|Bone necrosis|Necrosis of bone|OSTEONECROSIS|necrosis of bone|Osteonecroses|Bone Necroses|Bone necrosis (disorder)|Osteonecrosis|Bones--Necrosis|osteonecrosis | Bone necrosis |
C1210684 | null | Hipposideros armiger terasensis | Hipposideros terasensis |
C0045968 | An unsaturated aldehyde with commercial applications, including the manufacture of sorbic acid, that is also found in tobacco smoke, gasoline and diesel engine exhausts, and smoke from wood burning. Airborne exposure to this chemical can cause eyes, nose, throat, and lung irritation. | 2-Butenaldehyde|Propylene Aldehyde|1-Formylpropene|2-Butenal|Crotylaldehyde|Methylpropenal|2-butenal|Crotonaldehyde (substance)|Crotonaldehyde|3-Methylacrolein|Crotonic Aldehyde|crotonaldehyde|Beta-Methylacrolein | 2-butenal |
C0032005 | A small, unpaired gland situated in the SELLA TURCICA. It is connected to the HYPOTHALAMUS by a short stalk which is called the INFUNDIBULUM. | Pituitary structure|Hypophysis Cerebrus|Pituitary gland|glandula pituitaria|Hypophyses|Hypophyseal|Cerebrus, Hypophysis|Pituitary Gland|pituitary glands|Pituitary Glands|Pituitary structure (body structure)|PITUITARY GLAND|hypophyseal|pituitary gland|GLAND, PITUITARY|Pituitary gland, NOS|Hypophysis cerebri|pituitary|Nervous System, Pituitary|Gland, Pituitary|Hypophysis Cerebri|Cerebri, Hypophysis|Glands, Pituitary|Hypophysis|Glandula pituitaria|Pituitary|hypophysis | Pituitary Gland |
C0205095 | Pertaining to the back or upper surface of the body; opposite of ventral. | Back|of back|Retro-|Posterior (qualifier value)|back of|POSTERIOR|retro|Behind|Behind (qualifier value)|retro-|Posterior|BACK|DORSAL|Dorsal (qualifier value)|Dorsal|Back of|dorsal|posterior|behind|Dx - Dorsal | Dorsal |
C0040786 | Specialized hospital facilities which provide diagnostic and therapeutic services for trauma patients. | centers trauma|center trauma|Trauma center (environment)|Trauma centre|Center, Trauma|trauma centers|trauma center|Trauma Center|Trauma centers|Centers, Trauma|Trauma center | Trauma Centers |
C0597457 | null | skeletal injury|injuries skeletal | skeletal injury |
C0037944 | Narrowing of the spinal canal. | SPINAL STENOSIS|Spinal stenosis (disorder)|Spinal stenosis|Spinal Stenosis|Spinal stenosis, unspecified region|spinal narrowing|spinal stenosis|Spinal stenosis, NOS|SS - Spinal stenosis|Spinal Stenoses|Stenoses, Spinal|Stenosis, Spinal|Spinal stenoses | Spinal Stenosis |
C0870433 | The feeling of being displeased and discontent. | dissatisfaction|Dissatisfied|Dissatisfaction | Dissatisfaction |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.